Fluorescent light helps surgeons target brain tumors

At Leica we are proud that our products provide surgeons with enhanced visualization so they can preserve or improve quality of life for their patients. A recent broadcast by the US network Fox News describes how a substance called 5-aminolevulinic acid (5-ALA), used with FL400 fluorescence from Leica, supported a neurosurgeon during a successful brain... Read more

Upgradeable ophthalmic surgery solutions

“With rapidly evolving medical technologies, we do not know what will come along — even in the near future — so it makes sense to have the ability to expand.” Seenu M. HariprasadMD Chief of the Vitreoretinal Service, Director of Clinical Research and Shui-Chin Lee Professor of Ophthalmology and Visual Science at University of Chicago.... Read more

Agilent Technologies to Present at 35th Annual J.P. Morgan Healthcare Conference

SANTA CLARA, Calif.–(BUSINESS WIRE)–Jan. 3, 2017– Agilent Technologies Inc. (NYSE: A) today announced the following webcast for the investment community: 35thAnnual J.P. Morgan Healthcare ConferenceWestin St. Francis Hotel, San Francisco, CaliforniaTuesday, Jan. 10, 2017, at 3:00 p.m. PTMike McMullen, Agilent president and chief executive officer A link to the webcast will be available at www.investor.agilent.com.... Read more

Paragon Genomics graduated from Stanford StartX Accelerator Program

Paragon Genomics, a life sciences company dedicated to improving the critical upfront target enrichment and library preparation workflow for Next-Generation Sequencing and moving precision medicine forward, graduated from Stanford’s Fall 2016 StartX Accelerator Program. StartX Accelerator Program is a highly-intensive, 16-week program that accepts just 7-8 percent of applicants for its Spring and Fall sessions each year. The Founders of the Company has received... Read more

Agilent Technologies to Acquire Multiplicom N.V., a Leading European Diagnostics Company with State-of-the-Art Genetic Testing Technology and Products

Agilent fortifies its target-enrichment portfolio through its planned acquisition of Multiplicom N.V. SANTA CLARA, Calif. & NIEL, Belgium–(BUSINESS WIRE)–Dec. 20, 2016– Agilent Technologies Inc. (NYSE:A) and Multiplicom N.V. today announced that they have signed a definitive agreement under which Agilent will acquire Multiplicom, a leading European diagnostics company with state-of-the-art genetic testing technology and products.... Read more